Analyses / PLTR
High-growth AI/data platform at extreme valuations; hedge fund interest rising amid profitability narrative shift.
A free account reveals PLTR's entry zone, price target & stop loss. Full 1-week to 1-year price forecasts are included with Pro.
The Thesis
▲ Bull Case
32.9% YoY revenue growth + 36.3% net margin indicate durable profitability without dependency on losses. Strong balance sheet (7.1x current ratio). Hedge fund accumulation + AI narrative tailwinds may sustain momentum. Operating margin of 31.6% suggests pricing power and operational leverage.
▼ Bear Case
P/E 129x, forward 181x, P/S 66x are historically extreme even for high-growth software. Price down 40% from 52-week high; valuation compression risk remains if growth slows. Heavy insider selling (489 sells vs 50 buys) signals caution at current levels. High beta (1.57) amplifies downside volatility.
Valuation
OVERVALUED at current price — score 25/100
All major multiples are in the 95th+ percentile: P/E 129x, forward P/E 181x, P/S 66x, EV/EBITDA 217x. Even accounting for 33% revenue growth, fair value multiples for comparable high-growth software are 25-40x forward P/E. Current pricing implies 40%+ CAGR indefinitely or multiple expansion upon profitability proof.
Technical Levels
Support · $120.00 (Short-term technical support / 10-day MA region) · $106.37 (52-week low; major support if broken)
Resistance · $127.28 (Today's high; near-term cap) · $140.00 (Psychological level / 50-day MA approx) · $165.00 (Retest of 200-day MA if bull case holds)
RSI: Not provided
Financial Health
Score 82/100. Balance sheet is fortress-like: 7.1x current ratio, strong margins, minimal near-term solvency risk. However, book value of $3.09 vs. price of $123 suggests most value is intangible (brand, contracts, TAM). Profitability is sustainable but contingent on TAM growth.
Catalysts
| Q4 earnings / FY guidance update | Next 4-8 weeks (likely late Jan 2025) | high |
| AI product roadmap expansion / new vertical wins (gov, commercial) | Ongoing; may surface at earnings or in press releases | high |
| Customer concentration / large deal wins | Quarterly reports, investor updates | medium |
| Insider trading activity shift (if buying accelerates) | Ongoing; track 10-b filings | medium |
| Tech sector / growth stock sentiment (macro rates, recession fears) | Daily; typically exogenous | high |
Risk Flags
See PLTR's full trade plan — free
Create a free account to unlock the exact entry, target, and stop — plus run live analysis on any of 5,000+ tickers. No card required.
Unlock PLTR free →Recent News
- The Bull and Bear Case for Palantir, According to Wall StreetYahoo
- Prediction: This Will Be Palantir's Stock Price in a Year (Hint: It's Time to Buy)Yahoo
- Did AI Momentum and France's Exit Just Shift Palantir Technologies' (PLTR) Investment Narrative?Yahoo
- Smart Money Shifts: Palantir (PLTR) Gains Hedge Fund Backing as Snowflake (SNOW) Sees TrimsYahoo
You've read your 2 free analyses
Create a free account for unlimited analyses — every name on the page, plus live tools on 5,000+ tickers. No card required.
Read the full PLTR analysis — free →Free to read · 2 analyses every 30 days without an account
More Analyses
PLTR FAQ
Is PLTR a buy right now?
Palantir Technologies Inc's current read is a growth / profitability inflection setup with 62 confidence over a 6-12 months horizon. Valuation: OVERVALUED at current price. See the full bull and bear case above, or run a live analysis for the exact entry, target and stop.
Is PLTR overvalued?
OVERVALUED at current price (valuation score 25/100). All major multiples are in the 95th+ percentile: P/E 129x, forward P/E 181x, P/S 66x, EV/EBITDA 217x. Even accounting for 33% revenue growth, fair value multiples for comparable high-growth software are 25-40x forward P/E. Current pricing implies 40%+ CAGR indefinitely or multiple expansion upon profitability proof.
What are the risks of buying PLTR?
P/E 129x, forward 181x, P/S 66x are historically extreme even for high-growth software. Price down 40% from 52-week high; valuation compression risk remains if growth slows. Heavy insider selling (489 sells vs 50 buys) signals caution at current levels. High beta (1.57) amplifies downside volatility.